Enterome, Synthetic Biologics Collaborate on Research into Effects of Antibiotics on Gut Microbiome | GenomeWeb

NEW YORK (GenomeWeb) – Enterome and Synthetic Biologics will conduct microbiome research on the effects of beta-lactam antibiotics on humans as part of an agreement announced today.

The deal includes a clinical microbiome study of about 100 patients anticipated to begin in July, which could aid Synthetic Biologics as it further develops SYN-004 for protecting the gut microbiome from the effects of intravenous beta-lactam antibiotics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.